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Mitochondrial reactive oxygen species activate the slow
force response to stretch in feline myocardium
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When the length of the myocardium is increased, a biphasic response to stretch occurs involving
an initial rapid increase in force followed by a delayed slow increase called the slow force response
(SFR). Confirming previous findings involving angiotensin II in the SFR, it was blunted by
AT1 receptor blockade (losartan). The SFR was accompanied by an increase in reactive oxygen
species (ROS) of ∼30% and in intracellular Na+ concentration ([Na+]i) of ∼2.5 mmol l−1
over basal detected by H2DCFDA and SBFI fluorescence, respectively. Abolition of ROS by
2-mercapto-propionyl-glycine (MPG) and EUK8 suppressed the increase in [Na+]i and the SFR,
which were also blunted by Na+/H+ exchanger (NHE-1) inhibition (HOE642). NADPH oxidase
inhibition (apocynin or DPI) or blockade of the ATP-sensitive mitochondrial potassium channels
(5HD or glybenclamide) suppressed both the SFR and the increase in [Na+]i after stretch,
suggesting that endogenous angiotensin II activated NADPH oxidase leading to ROS release
by the ATP-sensitive mitochondrial potassium channels, which promoted NHE-1 activation.
Supporting the notion of ROS-mediated NHE-1 activation, stretch increased the ERK1/2 and
p90rsk kinases phosphorylation, effect that was cancelled by losartan. In agreement, the SFR
was cancelled by inhibiting the ERK1/2 signalling pathway with PD98059. Angiotensin II at a
dose that mimics the SFR (1 nmol l−1) induced an increase in ·O2− production of ∼30–40%
detected by lucigenin in cardiac slices, an effect that was blunted by losartan, MPG, apocynin,
5HD and glybenclamide. Taken together the data suggest a pivotal role of mitochondrial ROS in
the genesis of the SFR to stretch.
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During myocardial stretch, as the length of the cardiac
muscle increases, a corresponding rapid then slow increase
in twitch force occurs (Parmley & Chuck, 1973; Allen
& Kentish, 1985). The rapid change in force that forms
the basis of the Frank–Starling mechanism is believed
to be due to a sudden increase in myofilament Ca2+
responsiveness. The slow force response (SFR) was first
described by Parmley & Chuck (1973) as an increase in
contractility that developed over approximately 10 min
after the initial rapid change. The SFR may possibly
explain the Anrep effect which was first described by
von Anrep (1912). The Anrep effect is the response to
an elevation in aortic pressure, which involves an initial
increase in ventricular volume followed by a subsequent
decrease towards the original volume. Sarnoff et al. (1960)
called this phenomenon ‘pressure-induced homeometric
autoregulation’ and showed that catecholamines did not
have a significant role in this mechanism. Interestingly,
these authors defined ‘homeometric autoregulation’ as
a phenomenon that occurred in an organ that was not
attributable to nerves or chemical influences originating
in the vicinity of that organ. Based on these observations, it
was hypothesized that an autocrine/paracrine mechanism
may be activated after stretching of the cardiac muscle.
The SFR has been detected in isolated myocytes (White
et al. 1995), in strips of cardiac muscle (Parmley & Chuck,
1973; Kentish & Wrzosek, 1998; Alvarez et al. 1999; Pérez
et al. 2001) as well as in isolated blood perfused hearts
(Tucci et al. 1984; Burkhoff et al. 1991) and anaesthetized
dogs (Lew, 1993). However, the mechanism by which the
SFR develops is controversial. Based on pharmacological
interventions, we have previously proposed that the
myocardial stretch releases preformed angiotensin II
(Ang II), which induces the release/formation of endo-
thelin (ET) through AT1 receptors (Alvarez et al. 1999;
Pérez et al. 2001). Ang II/ET activates intracellular
signalling pathways that lead to activation of the Na+/H+
exchanger (NHE-1), and an increase in intracellular Na+
C° 2007 The Authors. Journal compilation C° 2007 The Physiological Society DOI: 10.1113/jphysiol.2007.141689
896 C. I. Caldiz and others J Physiol 584.3
concentration ([Na+]i) followed by an increase in the Ca2+
transient through the Na+/Ca2+ exchanger (NCX). Our
hypothesis concerning the role of the increase in [Na+]i
in driving the reverse NCX has been confirmed by several
authors (von Lewinski et al. 2004; Calaghan & White, 2004;
Luers et al. 2005), but the mechanism that leads to this
increase in [Na+]i has been challenged (Isenberg et al. 2005;
Calaghan & White, 2004). If our hypothesis is correct, then
the SFR is the result of a signalling cascade triggered by AT1
receptor activation.
Recent studies have suggested that reactive oxygen
species (ROS) may act as intracellular signalling markers
of Ang II/ET-1 in the myocardium (Sugden & Clerk, 2006)
as well as after myocardial stretch (Pimentel et al. 2006).
In addition, we have recently reported that in isolated
cat myocytes, 1 nmol l−1 Ang II increased sarcomere
shortening by approximately 30% and exerted their action
entirely through an autocrine crosstalk with endogenous
ET-1 (Cingolani et al. 2006). Furthermore, this effect
was accompanied by an increase in ROS production and
inhibited by the prevention of ROS formation. Here, we
explore the possible participation of ROS in the generation
of the SFR during myocardial stretch.
Methods
All procedures followed during this investigation conform
to the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication no. 85–23, revised 1996) and to the guidelines
laid down by the Animal Welfare Committee of the La
Plata School of Medicine. Cats (body weight 3–4 kg)
were anaesthetized by intraperitoneal injection of sodium
pentobarbitone (35 mg (kg body weight)−1). The chests
were opened to excise the heart when deep anaesthesia
was reached, verified by the loss of the corneal reflex
and appearance of slow deep diaphragmatic breathing.
Animals were provided by a local supplier (San Cayetano,
Monte Grande, Argentina). Forty-six cats were used in the
study. Each heart was used to provide papillary muscles as
well as cardiac tissue slices.
Isolated papillary muscles
Isolation of cat papillary muscles. Papillary muscles
from the right ventricle were used to assess the SFR
to stretch as previously described (Pérez et al. 2001).
Briefly, the muscles were mounted in a perfusion chamber
placed on the stage of an inverted microscope (Olympus)
for epifluorescence measurements and superfused at a
constant rate (5 ml min−1) with a CO2/HCO3− -buffered
solution containing (mmol l−1): NaCl 128.3, KCl 4.5,
CaCl2 1.35, NaHCO3 20.23, MgSO4 1.05, glucose 11.0
and equilibrated with 5% CO2–95% O2 (pH ∼7.40). The
possible participation of cathecholamines released by
the nerve endings was prevented by adrenergic receptor
blockade with 1.0 μmol l−1 prazosin plus 1.0 μmol l−1
atenolol. The muscles were paced at 0.2 Hz at a voltage 10%
over threshold and maintained at 30◦C, and isometric
contractions were recorded. Cross-sectional area
(calculated as 0.75 of the product of thickness by width)
was used to normalize force records obtained with
a silicon strain gauge (model AEM 801, SensoNor).
The slack length of each muscle was determined after
mounting, and then the muscles were progressively
stretched to the length at which they developed maximal
twitch force (Lmax). After a few minutes at Lmax, they
were shortened to obtain the 95% of the maximal
twitch force (length that approximated 98% of Lmax and
referred to as L98). Then, the muscles were shortened to
92% of Lmax (L92) and maintained at this length until
the beginning of the experimental protocol, during
which the muscles were abruptly stretched from L92
to L98. In those experiments with pharmacological
interventions, the drugs were added ∼20 min before the
stretch. None of the drugs changed basal contractility
significantly.
Determination of [Na+]i by epifluorescence. The
papillary muscles were loaded with sodium-binding
benzofuran isophthalate (SBFI, AM form). The
esters were daily prepared as 1 mmol l−1 solution in
dimethylsulfoxide (DMSO) plus Pluronic F-127 (20%
w/w in DMSO) at a ratio of 4 : 1 to help disperse the
indicators in the loading medium. Loading time lasted
2 h (SBFI final concentration 10 μmol l−1) at room
temperature (22–24◦C). The excitation wavelengths were
340 and 380 nm for SBFI and the emitted fluorescence
was monitored after passage through a 535 ± 5 nm filter.
The ratio 340/380 (SBFI) of emitted fluorescence was
performed off-line after subtraction of the corresponding
autofluorescence value at each wavelength. The values of
[Na+]i were estimated from ‘in vivo’ calibrations of SBFI
fluorescence performed at the end of each experiment
according to Harootunian et al. (1989) with 2.0 μmol l−1
gramicidin, 5.0 μmol l−1 monensin and 0.05 mmol l−1
ouabaine.
Reactive oxygen species measurements. Intracellular
ROS production was measured in isolated papillary
muscles by epifluorescence of dichloride-hydrofluorescein
diacetate (H2DCFDA) (Keller et al. 2004). The muscles
were incubated with 20 μmol l−1 H2DCFDA at room
temperature for 1 h. The muscles were excited at 495 nm
and the emitted light collected after passage through a
535 ± 5 nm filter. Before obtaining the signal, background
fluorescence was subtracted.
C° 2007 The Authors. Journal compilation C° 2007 The Physiological Society
J Physiol 584.3 Reactive oxygen species and slow force response to stretch 897
Cardiac tissue slices
Preparation of cardiac slices. Hearts were quickly
removed from previously anaesthetized animals. The
hearts were perfused through the aorta with Krebs–Ringer
buffer pH 7.4 to eliminate the blood, and tissue slices from
the left ventricle (1 × 5 mm) were cut and kept at 4◦C
until assayed. Assay buffer consisted of Krebs-Hepes buffer
of the following composition (mmol l−1): 118.3 NaCl; 4.7
KCl; 1.8 CaCl2; 1.2 MgSO4; 1.0 K2HPO4; 25 NaHCO3; 11
glucose; 20 Hepes (pH 7.4 after 1.5 h aeration with 95%
O2–5% CO2 at 37
◦C). Cardiac tissue were incubated in
the assay buffer during 30 min in the presence of different
drugs in a metabolic incubator under 95% O2–5% CO2 at
37◦C before measurements of ·O2− production.
Measurements of superoxide anion (·O2−) production.
We used lucigenin-enhanced chemiluminescence to
measure ·O2− production by cat cardiac tissue in
Krebs-Hepes buffer with 5 μmol l−1 lucigenin. The
chemiluminescence in arbitrary units (AU) was recorded
with a luminometer (Chameleon, Hidex) during
30 s each with 4.5 min interval during 30 min. The
lucigenin-containing assay buffer with tissue slices minus
background as well as responses to the different drugs
assayed were reported. ·O2− production was normalized
to milligrams dry weight tissue per minute. Control
tissue slices without any pharmacological intervention
produced low levels of ·O2− which was only slightly
above background. Although the lucigenin enhanced
chemiluminescence method does not allow accurate
detection of basal ·O2− production (Dikalov et al. 2007), its
sensitivity was enough to detect a dose-dependent increase
in ·O2− production above the background after 1 and
100 nmol l−1 Ang II (see Results). When necessary the
increase in ·O2− production was expressed as a percentage
of basal value after 15 min of each intervention.
Determination of extracellular signal-regulated protein
kinases (ERK1/2) and p90 ribosomal S6 kinase (p90rsk)
phosphorylation after stretch. At the end of the
protocols, the superfusion solution was quickly removed
and papillary muscles were homogenized in lysis buffer:
300 mmol l−1 sacarose; 1 mmol l−1 DTT; 4 mmol l−1
EGTA, protease inhibitors cocktail (Complete Mini
Roche); 20 mmol l−1 Tris-HCl, pH 7.4. After a brief
centrifugation the supernatant was kept and protein
concentration determined by the Bradford method.
Samples were denatured and equal amounts of protein
subjected to PAGE and electrotransferred to PVDF
membranes. After blocking with non-fat dry milk
membranes were incubated overnight either with
anti-P-p90rsk or anti P-ERK1/2 polyclonal antibodies
(Santa Cruz Biotechnology). A peroxidase-conjugated
anti-rabbit IgG (Santa Cruz Biotechnology) was used
as secondary antibody and finally bands were visualized
using the ECL-Plus chemiluminescence detection
system (Amersham). Autoradiograms were analysed by
densitometric analysis (Scion Image).
Chemicals
All drugs used in the present study were of analytical
grade. Ang II, lucigenin, 5-hydroxydecanoate (5HD),
diphenyleneiodonium chloride (DPI), N-2-mercap-
topropionyl-glycine (MPG) and polyethylene glycol-
superoxide dismutase (PEG-SOD) were purchased from
Sigma; glybenclamide was from RBI; apocynin was from
Fluka; losartan was from Merck; HOE642 was from
Aventis; EUK8 was from Calbiochem; PD98059 was
from Biosource. Either assay buffer or dimethyl sulfoxide
(DMSO) was used to prepare the drugs. For the superoxide
assay the final DMSO concentration was kept < 0.5%,
which did not interfere with the lucigenin signal.
Statistics
Data are expressed as means ± s.e.m. Differences between
initial phase and poststretch records, comparison of ·O2−
production after 15 min of incubation with the different
Figure 1
A, original force record from a papillary muscle subjected to an
increase in length from L92 to L98; the biphasic response to stretch can
be seen. B, suppression of the SFR (expressed as a percentage of the
initial rapid phase) after AT1 but not AT2 receptor blockade (losartan
and PD123,319, respectively). DF, developed force. ∗P < 0.05 control
and PD123,319 versus Losartan.
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drugs and ERK1/2 and p90rsk phosphorylation under the
different conditions were assessed by one-way ANOVA
followed by Student–Newman–Keuls test. Two-way
ANOVA was used to compare post-stretch data in the
absence and presence of drugs and the time course of
different curves in the lucigenin experiments. P < 0.05 was
considered significant.
Results
Figure 1A shows an original record of twitch-developed
force from a cat papillary muscle that was subjected to an
Figure 2
A, myocardial stretch induced an intracellular ROS increase of ∼30% above the baseline levels that was cancelled
by the ROS scavengers MPG and EUK8. B, MPG and EUK8 also cancelled the SFR (expressed as percent of the
initial rapid phase). C, furthermore, ROS scavenging also blunted the stretch-induced increase in [Na+]i. Insets
show original raw data for ROS production (A), force (B) and intracellular [Na+] (C). DF, developed force. ∗P < 0.05
control versus MPG and EUK8.
increase in length from L92 to L98. It can be seen that the
SFR developed during the 10–15 min following the initial
rapid increase in force. The SFR, depicted as a percentage
of the initial rapid phase, was suppressed by inhibition of
AT1 but not AT2 receptors (Fig. 1B). Previous studies from
our laboratory have suggested that the SFR is the result of
an autocrine/paracrine loop beginning with the release of
Ang II and ending with an increase in the Ca2+ transient
through the NCX, without changes in the myofilament
Ca2+ responsiveness during its development (for review
see Cingolani et al. 2005). The activation of reverse NCX
that follows an increase in [Na+]i and is responsible for
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an increase in the Ca2+ transient has been described by
several authors including ourselves for myocardial stretch
(Alvarez et al. 1999; Pérez et al. 2001; von Lewinski et al.
2004; Calaghan & White, 2004; Luers et al. 2005) and
for other experimental conditions (Weisser-Thomas et al.
2003; Pérez et al. 2003; Aiello et al. 2005; Bers et al.
2006). Interestingly, a mathematical model that analysed
the potential contribution of sarcolemmal ion fluxes to
the development of the SFR predicted that this route was
a suitable mechanism for regulating the increase in Ca2+
entry into the cells after stretch, without involvement of
the sarcoplasmic reticulum (Bluhm et al. 1998).
The magnitude of the SFR can be mimicked by
exogenous addition of 1.0 nmol l−1 Ang II and inhibition
of the ET receptors abolishes this inotropic effect (Pérez
et al. 2003). However, AT1 receptor blockade failed to
abolish the inotropic response to an equipotent dose of
exogenous ET-1 (Perez et al. 2003). Thus, the crosstalk
between both peptides appears to be Ang II to ET and not
the other way around. In addition, we have reported an
increase in ET-1 mRNA after treatment with 1 nmol l−1
Ang II as well as the presence of preproET, bigET and ET
in adult cat isolated myocytes (Cingolani et al. 2006).
Figure 3.
NHE-1 blockade with HOE642 cancelled both the SFR (expressed as a percentage of the initial rapid phase) (A)
and the increase in [Na+]i (B) Insets show original raw data for force (A) and intracellular [Na+] (B). DF, developed
force. ∗P < 0.05 control versus HOE642.
Recently, we emphasized the role of ROS formation in
activation of the intracellular signalling pathway triggered
by physiological doses of Ang II/ET in the myocardium
(Cingolani et al. 2006; Villa-Abrille et al. 2006). Since the
SFR appears to be due to these peptides, we examined the
effects of stretch upon ROS formation on cat papillary
muscles by H2DCFDA fluorescence. Figure 2A shows that
stretch, in addition to its mechanical effect, induced an
increase in intracellular ROS formation of approximately
30% above baseline levels. Furthermore, scavenging of
ROS by MPG (2.0 mmol l−1) or EUK8 (50 μmol l−1)
inhibited both the stretch-induced increase in ROS
(Fig. 2A) and the SFR (Fig. 2B). We also found that the
scavenging of ROS inhibited the increase in [Na+]i that
occurs in response to the stretch (Fig. 2C). Figure 3 shows
inhibition of both the increase in [Na+]i and the SFR
following NHE-1 blockade with HOE642 (1 μmol l−1).
Previous studies have described a phenomenon called
‘ROS-induced ROS-release’, by which a small amount of
ROS (not detected by the usual techniques) activates a
larger ROS production from the mitochondria (Zorov et al.
2000; Kimura et al. 2005a). Based on the assumptions
that Ang II is involved in the SFR to stretch and activates
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NADPH oxidase (NOX) (Lavigne et al. 2001; Kimura et al.
2005b), we hypothesized that activation of NOX after
stretch would produce a small amount of ·O2−, which
may open the ATP-sensitive mitochondrial potassium
(mKATP) channels and produce a larger amount of ·O2−
responsible for generating the SFR. Although there is no
direct evidence to demonstrate that activation of NOX
is required to open mKATP channels, previous studies
showing that reconstituted mKATP channels are opened
by ·O2− give support to this proposed mechanism (Zhang
et al. 2001). Furthermore, other reports have proposed
that an interaction between mKATP channels and NHE-1
inhibition may be involved in protection against myo-
cardial ischaemia (Miura et al. 2001; Fantinelli et al.
2006). Therefore, if our assumptions are correct, the
SFR should be abolished by either NOX inactivation or
blockade of mKATP channels. As shown in Fig. 4A, the
SFR was abolished after inhibition of NOX with apocynin
or DPI or after blockade of mKATP channels with 5HD
or glybenclamide. The NHE-1-induced increase in [Na+]i
Figure 4
A, NOX inhibition by apocynin (Apo) or DPI as well as mKATP channel blockade with 5HD or glybenclamide (Gly)
abolished the SFR (expressed as a percentage of the initial rapid phase). B, these interventions also cancelled
the NHE-1-induced increase in [Na+]i that accompanied the SFR. Insets show original raw data for force (A) and
intracellular [Na+] (B). DF, developed force. ∗P < 0.05 control versus all other groups.
that accompanies the SFR was also abolished by these inter-
ventions (Fig. 4B).
Previous studies have shown that the sarcoplasmic
reticulum is not involved in the generation of the SFR
(Bluhm & Lew, 1995; Hongo et al. 1995; Kentish &
Wrzosek, 1998). Based on these studies and on the findings
reported here, it would be reasonable to conclude that
mitochondrial ·O2− or H2O2 production after stretch may
lead to phosphorylation and activation of the NHE-1. It
has previously been shown that activation of the NHE-1
after stretch is followed by an increase in [Na+]i without
significant changes in intracellular pH when bicarbonate
is present in the medium, due to simultaneous activation
of the Na+-independent Cl−/HCO3− exchanger (Alvarez
et al. 1999; Pérez et al. 2001). ROS-mediated activation
of the NHE-1 is reportedly due to kinase-mediated
phosphorylation of the cytosolic tail of the exchanger, with
MEK, ERK1/2 and p90rsk kinases being the most likely
candidates that mediate this effect (Rothstein et al. 2002).
With respect to these findings, RAS-dependent activation
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of these kinases has been recently reported after stretch
in neonatal cardiomyocytes (Pimentel et al. 2006). Here,
we detect a significant increase in ERK1/2 and p90rsk
phosphorylation after 15 min of stretch (Fig. 5A). This
effect was abolished by treatment with 1 μmol l−1 losartan
(Fig. 5A). In addition, we show that inhibition of MEK (a
kinase that is upstream of ERK1/2 and downstream of
RAS) by PD98059 (50 μmol l−1) also abolished the SFR
(Fig. 5B).
Taken together, these data appear to support the
hypothesis that the stretch triggers the release/formation
of Ang II/ET, which in an autocrine/paracrine manner
leads to NOX activation, ·O2− production, opening
of mKATP channels and increased mitochondrial ·O2−
production. The mitochondrial ·O2− or H2O2 (after
dismutation) may activate the ERK1/2–p90rsk pathway
leading to phosphorylation and activation of the NHE-1,
thereby increasing [Na+]i and generating the SFR through
the NCX. It is known that the increase in [Na+]i can
induce an increase in intracellular Ca2+ levels through
the NCX as a result of a decrease in Ca2+ efflux
Figure 5
A, myocardial stretch significantly increased ERK1/2 and p90rsk
phosphorylation, an effect that was cancelled by losartan (Los).
B, inhibition of MEK (a kinase upstream ERK1/2 and downstream RAS)
by PD98059 cancelled the SFR (expressed as a percentage of the initial
rapid phase). DF, developed force. ∗P < 0.05 versus non-stretched
control (cont); †P < 0.05 control versus PD98059.
(decreased forward mode) and/or an increase in Ca2+
entry (increased reverse mode). If our hypothesis is correct,
then small doses of exogenous Ang II should increase ·O2−
production in a NOX and mKATP channel-dependent
manner. In addition, this response should be inhibited
by losartan, apocynin, 5HD and glybenclamide. To test
this hypothesis, we examined the effect of exogenous
Ang II on ·O2− production (determined by the lucigenin
chemiluminescence method) in cat myocardial slices
(Fig. 6). As shown in Fig. 6A, Ang II (1 and 100 nmol l−1)
induced a dose-dependent increase in ·O2− production
which was blocked by losartan (1 μmol l−1) and MPG
(2 mmol l−1). These compounds did not affect basal
Figure 6
A, dose-dependent effect of 1 nmol l−1 (n = 34) and 100 nmol l−1
Ang II (n = 14) on superoxide generation by myocardial slices. Ang II (1
and 100 nmol l−1) significantly increased superoxide production above
the control lucigenin level (tissue minus background) (P < 0.05). The
effect of 100 nmol l−1 Ang II was abolished in the presence of losartan
(Los, n = 5) and MPG (n = 3) blunted the superoxide production
induced by 1 nmol l−1 Ang II. B, luminescence values of the tissue in
the absence of drugs (Control, n = 32), and in the presence of Los
(n = 8) and MPG (n = 7). Note that the basal value was unaffected by
the scavenger MPG, demonstrating that it was not due to a basal
·O2− production by the tissue.
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background levels (Fig. 6B). Figure 7 shows that at this
dose the Ang II-induced increase in the rate of ·O2−
production was NOX dependent since it was suppressed by
apocynin (300 μmol l−1). The NOX-dependent increase in
·O2− production was also abolished by mKATP channel
blockade with 5HD (100 μmol l−1) or glybenclamide
(50 μmol l−1).
Since changes in ROS levels were measured by
H2DCFDA fluorescence, we were unable to determine
whether the intracellular mediator that led to the activation
of kinases responsible for the NHE activation was ·O2− or
H2O2. NOX-generated ·O2− is very unstable and rapidly
converted into H2O2 by the superoxide dismutase (SOD), a
more stable membrane permeant ROS, widely recognized
as a signalling molecule. In the myocardium, dismutation
is performed by a membrane bound extracellular SOD
as well as by cytoplasmic CuZn and mitochondrial
Mn isoforms of SOD. Therefore, the ·O2− detected in
cardiac slices may be easily converted into H2O2 at
different cellular locations upstream or downstream of the
mitochondria.
If the intracellular signal activating the SFR is H2O2
and not ·O2−, then dismutation of ·O2− to H2O2 would
presumably enhance this effect. In contrast, the SFR would
decrease if the intracellular signalling pathway involved
·O2−. Figure 8 shows that when the papillary muscles were
stretched in the presence of PEG-SOD (100 units ml−1),
the SFR almost doubled compared with controls. Although
addition of PEG-SOD produced a negative inotropic
effect in three out of six muscles, the SFR was always
of the same order of magnitude, i.e. approximately 45%
Figure 7
Superoxide production induced by 1 nmol l−1 Ang II (n = 34) in the
absence and presence of 1 μmol l−1 losartan (Los, n = 8),
300 μmol l−1 apocynin (Apo, n = 7), 100 μmol l−1 5HD (n = 10) and
50 μmol l−1 glybenclamide (Gly, n = 6). Since superoxide production
stabilized after 15 min (see Fig. 6), the data obtained at this time are
expressed as a percentage of control values without additions. Inset
shows the lack of effect of all drugs used upon the basal
measurement. ∗P < 0.05 versus control.
higher than the initial rapid phase. The larger SFR under
these conditions suggests that dismutation of intracellular
·O2− to H2O2 induced the positive inotropic effect.
Experiments by Sabri et al. (1998) and Rothstein et al.
(2002) indicated that H2O2 is the intracellular signal
leading to the activation of kinases that phosphorylate the
NHE.
Discussion
During the last few years, the view about the deleterious
effect of ROS has changed with the recognition that
both ·O2− and H2O2 can play important roles in signal
transduction through specific modification of signalling
proteins. Here, we present evidence that a known physio-
logical phenomenon, the Anrep effect, which can be
reproduced in myocardial strips and is represented by the
SFR, is the result of mitochondrial-derived ROS targeting
the NHE-1. Previous reports by our group (Alvarez et al.
1999; Pérez et al. 2001) and others (Yamazaki et al. 1998;
Figure 8
A, original force record from a papillary muscle subjected to an
increase in length from L92 to L98 in the presence of 100 units ml−1 of
PEG-SOD; there is a greater SFR than that shown under control
conditions (see Fig. 1). As stated in the main text, although addition of
PEG-SOD produced a negative inotropic effect in three out of six
muscles, the SFR was always of the same order of magnitude. The
original record shown here belongs to a muscle in which no decrease
in force after PEG-SOD addition was observed. B, averaged results for
the SFR (expressed as a percentage of the initial rapid phase) under
control conditions and after preincubation with PEG-SOD. DF,
developed force. ∗P < 0.05 control versus PEG-SOD.
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Calaghan & White, 2004; von Lewinski et al. 2004) have
proposed that the NHE-1 has a role in the development of
the SFR after myocardial stretch.
In this study, we show that the SFR and the
increase in [Na+]i that follows myocardial stretch can be
abolished by ROS scavenging. In addition, we report that
myocardial stretch induced an AT1-dependent increase
in ERK1/2 and p90rsk phosphorylation. These findings
indirectly support the theory that the myocardial stretch
activates the NHE-1. We also show that doses of Ang
II that mimic the SFR increase ·O2− production in a
NOX-dependent manner. Our data suggest that small
and/or localized amounts of ·O2− produced after NOX
activation by Ang II induce a greater increase in ·O2−
production as a consequence of mKATP channels opening,
since this effect was not observed in the presence of
the mKATP channel blockers, 5HD and glybenclamide.
Furthermore, 5HD and glybenclamide also abolished
the SFR and NHE-1 mediated increase in [Na+]i. Our
findings suggest that activation of the NHE-1 probably
occurred after ERK1/2 and p90rsk phosphorylation,
since the increased phosphorylation of both kinases
after stretch was abolished by inhibition of the AT1
receptors.
The activation of NHE-1 by H2O2 is reportedly the
result of kinases that lead to phosphorylation of the
cytosolic tail of the exchanger (Sabri et al. 1998; Rothstein
et al. 2002). MEK, ERK1/2 and p90rsk kinases are all
suitable candidates that could potentially mediate this
effect. Interestingly, a recent study in neonates reported
RAS-dependent activation of these kinases after stretch
(Pimentel et al. 2006). Sabri et al. (1998) showed that
NHE activity was stimulated after neonatal rat ventricular
myocytes were briefly exposed to H2O2 and that this
Figure 9. Schematic proposed mechanism leading to the SFR
Myocardial stretch induces release of preformed Ang II, which through AT1 receptors promotes release/formation
of ET. ET, by activation of NOX generates ·O2− which by a ‘ROS-induced ROS-release’ mechanism produces a
greater amount of ·O2− from the mitochondria, which activates the ERK1/2–p90rsk cascade leading to NHE-1
phosphorylation, increasing [Na+]i through the NHE-1 and Ca2+ through the NCX. The fact that a low dose of
Ang II induces its effects entirely by endogenous ET encourages us to propose ET and not Ang II as the activator
of NOX. However, we cannot rule out the possibility of some additional direct action of Ang II on NOX at higher
Ang II doses.
effect was completely abolished by pretreatment with
the MEK inhibitor, PD98059. Furthermore, it has been
reported that H2O2-induced Ca
2+ overload was partially
mediated by NHE-1 activation after phosphorylation of
the exchanger by the ERK1/2 MAP kinase pathway in
neonatal rat ventricular myocytes (Rothstein et al. 2002).
Taken together, our data and these previously reported
findings support the chain of events schematized in
Fig. 9.
Many studies have described the release of Ang II
after stretch. Sadoshima et al. (1993) were the first to
demonstrate that Ang II was the autocrine/paracrine
mediator of stretch-induced hypertrophy in neonatal
cardiomyocytes. At the same time, Ito et al. (1993)
found that Ang II promoted the release/formation of
ET-1 in neonatal cardiomyocytes. These observations
suggested that ET-1 was an autocrine/paracrine factor in
the mechanism of Ang II-induced cardiac hypertrophy.
In addition, it was also reported that stretch induced a
rise in the ET-1 concentration in the culture medium of
neonates (Yamazaki et al. 1996). Interestingly, Leri et al.
(1998) showed that stretch induced release of Ang II
in adult cardiomyocytes, whereas Leskinen et al. (1997)
demonstrated pharmacologically that Ang II and ET
were autocrine/paracrine mediators released after volume
expansion of the adult rat heart. Here, we show that
in the adult multicellular cat papillary muscle, increased
phosphorylation of kinases known to be activated by
Ang II/ET that target the NHE-1 occurred after myocardial
stretch in an AT1 receptor-dependent manner and through
a mechanism that appears to involve mitochondrial
ROS. Taken together our data suggest a pivotal role
of mitochondrial ROS in the genesis of the SFR to
stretch.
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Pérez are Established Investigators of CONICET, Argentina.
C° 2007 The Authors. Journal compilation C° 2007 The Physiological Society
